Revealed: 3 Stocks for Potentially Massive Gains
Here is the latest financial fact sheet of Abbott India. For more details, see the Abbott India quarterly results and Abbott India share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -0.7 |
No. of shares | m | 21.25 |
% ch week | % | -1.3 |
% ch 1-mth | % | 2.3 |
% ch 12-mth | % | -13.2 |
52 week H/L | Rs | 18,569.0/13,970.1 |
No. of Mths Year Ending |
12 Mar-15 |
12 Mar-16 |
12 Mar-17 |
12 Mar-18 |
12 Mar-19 |
5-Yr Chart Click to enlarge
|
---|
ABBOTT INDIA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 4,119 | 6,015 | 5,190 | 6,110 | 8,834 | |
Low | Rs | 3,700 | 3,707 | 4,351 | 3,996 | 5,458 | |
Sales per share (Unadj.) | Rs | 1,077.3 | 1,245.0 | 1,365.9 | 1,552.2 | 1,731.1 | |
Earnings per share (Unadj.) | Rs | 107.7 | 120.1 | 130.2 | 188.8 | 211.9 | |
Diluted earnings per share | Rs | 107.7 | 120.1 | 130.2 | 188.8 | 211.9 | |
Cash flow per share (Unadj.) | Rs | 114.8 | 126.9 | 137.9 | 196.4 | 219.9 | |
Dividends per share (Unadj.) | Rs | 31.00 | 35.00 | 40.00 | 55.00 | 65.00 | |
Adj. dividends per share | Rs | 31.00 | 35.00 | 40.00 | 55.00 | 65.00 | |
Dividend yield (eoy) | % | 0.8 | 0.7 | 0.8 | 1.1 | 0.9 | |
Book value per share (Unadj.) | Rs | 477.6 | 562.6 | 652.7 | 796.6 | 945.2 | |
Adj. book value per share | Rs | 477.6 | 562.6 | 652.7 | 796.6 | 945.2 | |
Shares outstanding (eoy) | m | 21.25 | 21.25 | 21.25 | 21.25 | 21.25 | |
Bonus/Rights/Conversions | - | - | - | - | - | ||
Price / Sales ratio | x | 3.6 | 3.9 | 3.5 | 3.3 | 4.1 | |
Avg P/E ratio | x | 36.3 | 40.5 | 36.6 | 26.8 | 33.7 | |
P/CF ratio (eoy) | x | 34.1 | 38.3 | 34.6 | 25.7 | 32.5 | |
Price / Book Value ratio | x | 8.2 | 8.6 | 7.3 | 6.3 | 7.6 | |
Dividend payout | % | 28.8 | 29.1 | 30.7 | 29.1 | 30.7 | |
Avg Mkt Cap | Rs m | 83,079 | 103,296 | 101,373 | 107,376 | 151,848 | |
No. of employees | `000 | 2.9 | 3.0 | 3.1 | 3.3 | 3.5 | |
Total wages/salary | Rs m | 3,054 | 3,411 | 3,453 | 3,937 | 4,356 | |
Avg. sales/employee | Rs Th | 7,985.1 | 8,950.1 | 9,414.7 | 9,929.3 | 10,555.5 | |
Avg. wages/employee | Rs Th | 1,065.2 | 1,153.9 | 1,119.9 | 1,185.1 | 1,249.9 | |
Avg. net profit/employee | Rs Th | 798.6 | 863.5 | 897.3 | 1,207.7 | 1,292.2 |
ABBOTT INDIA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 22,893 | 26,456 | 29,026 | 32,985 | 36,786 | |
Other income | Rs m | 476 | 506 | 576 | 1,170 | 1,133 | |
Total revenues | Rs m | 23,369 | 26,962 | 29,602 | 34,155 | 37,919 | |
Gross profit | Rs m | 3,123 | 3,644 | 3,973 | 5,245 | 6,047 | |
Depreciation | Rs m | 149 | 144 | 164 | 162 | 169 | |
Interest | Rs m | 5 | 25 | 20 | 38 | 23 | |
Profit before tax | Rs m | 3,444 | 3,980 | 4,365 | 6,215 | 6,989 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,154 | 1,428 | 1,598 | 2,203 | 2,485 | |
Profit after tax | Rs m | 2,290 | 2,553 | 2,767 | 4,012 | 4,503 | |
Gross profit margin | % | 13.6 | 13.8 | 13.7 | 15.9 | 16.4 | |
Effective tax rate | % | 33.5 | 35.9 | 36.6 | 35.4 | 35.6 | |
Net profit margin | % | 10.0 | 9.6 | 9.5 | 12.2 | 12.2 |
ABBOTT INDIA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 12,362 | 14,506 | 18,930 | 22,311 | 27,610 | |
Current liabilities | Rs m | 3,171 | 3,823 | 6,316 | 6,681 | 8,569 | |
Net working cap to sales | % | 40.1 | 40.4 | 43.5 | 47.4 | 51.8 | |
Current ratio | x | 3.9 | 3.8 | 3.0 | 3.3 | 3.2 | |
Inventory Days | Days | 61 | 51 | 63 | 65 | 60 | |
Debtors Days | Days | 21 | 20 | 22 | 29 | 27 | |
Net fixed assets | Rs m | 1,000 | 1,113 | 1,159 | 835 | 1,057 | |
Share capital | Rs m | 213 | 213 | 213 | 213 | 213 | |
"Free" reserves | Rs m | 9,938 | 11,744 | 13,657 | 16,715 | 19,873 | |
Net worth | Rs m | 10,150 | 11,956 | 13,869 | 16,928 | 20,086 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 13,665 | 16,165 | 20,658 | 24,162 | 29,409 | |
Interest coverage | x | 689.7 | 158.9 | 215.0 | 163.7 | 311.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.7 | 1.6 | 1.4 | 1.4 | 1.3 | |
Return on assets | % | 16.8 | 15.9 | 13.5 | 16.8 | 15.4 | |
Return on equity | % | 22.6 | 21.3 | 19.9 | 23.7 | 22.4 | |
Return on capital | % | 34.0 | 33.5 | 31.6 | 36.9 | 34.9 | |
Exports to sales | % | 0.5 | 0.6 | 0 | 0 | 0 | |
Imports to sales | % | 9.9 | 12.6 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 122 | 162 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 2,264 | 3,322 | 0 | 0 | 0 | |
Fx inflow | Rs m | 215 | 268 | 0 | 369 | 369 | |
Fx outflow | Rs m | 2,737 | 3,927 | 0 | 3,807 | 4,918 | |
Net fx | Rs m | -2,523 | -3,659 | 0 | -3,438 | -4,549 |
ABBOTT INDIA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,148 | 2,487 | 3,072 | 1,527 | 4,991 | |
From Investments | Rs m | -1,867 | -772 | -1,554 | -2,148 | -2,570 | |
From Financial Activity | Rs m | -576 | -803 | -898 | -1,024 | -1,428 | |
Net Cashflow | Rs m | -295 | 912 | 621 | -1,646 | 993 |
Share Holding
|
Company Information
|
CHM: Munir Shaikh | COMP SEC: Krupa Anandpara | YEAR OF INC: 1944 | BSE CODE: 500488 | FV (Rs): 10 | DIV YIELD (%): 0.4 |
More Pharmaceuticals Company Fact Sheets: SHASUN PHARMA PFIZER INDRAPRASTHA MEDICAL TORRENT PHARMA ORCHID PHARMA
Compare ABBOTT INDIA With: SHASUN PHARMA PFIZER INDRAPRASTHA MEDICAL TORRENT PHARMA ORCHID PHARMA
Compare ABBOTT INDIA With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.
For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
What should you do if the market falls? In this video, I'll tell you what I will do.
A favourable demand supply scenario makes a strong case for real estate prices.
Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market
More